Učitavanje...
Recent advances in medical therapy for metastatic urothelial cancer
Cytotoxic chemotherapy has been the mainstay of medical therapy for metastatic urothelial cancer. Currently, the gemcitabine/cisplatin regimen is widely used worldwide as the standard first-line medical treatment. Very recently, in 2017, pembrolizumab, a highly selective, humanized monoclonal IgG4κ...
Spremljeno u:
| Izdano u: | Int J Clin Oncol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Japan
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097083/ https://ncbi.nlm.nih.gov/pubmed/29556919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-018-1260-0 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|